Theravance Biopharma, Inc.TBPHNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank0
3Y CAGR-8.1%
5Y CAGR-21.4%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-8.1%/yr
vs -16.8%/yr prior
5Y CAGR
-21.4%/yr
Recent acceleration
Acceleration
+8.7pp
Accelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.3x
Contraction
Streak
5 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$111.07M-0.2%
2024$111.33M-1.9%
2023$113.46M-20.8%
2022$143.30M-54.2%
2021$313.10M-15.3%
2020$369.48M+13.6%
2019$325.33M+8.8%
2018$299.12M+8.6%
2017$275.51M+20.2%
2016$229.12M-